Cardiac events and dynamic echocardiographic and electrocardiogram changes following osimertinib treatment in lung cancer

Cardiac events and dynamic echocardiographic and electrocardiogram changes following osimertinib treatment in lung cancer

Osimertinib is first-line treatment for epidermal growth factor (EGFR)-mutated non-small cell lung cancer (NSCLC) and has been associated with cardiotoxicity. However, the nature of cardiac remodeling and associated risk factors remains incompletely understood. Retrospective analysis of NSCLC patien...

תיאור מלא

מידע ביבליוגרפי
Main Authors: Jonathan N. Le, Jordan O. Gasho, Olivia Peony, Asneh Singh, Katrina D. Silos, Sungjin Kim, Anthony T. Nguyen, Mitchell Kamrava, Amin Mirhadi, Behrooz Hakimian, Karen L. Reckamp, Kamya Sankar, Raymond H. Mak, Andriana P. Nikolova, Katelyn M. Atkins
פורמט: Article
שפה:English
יצא לאור: Frontiers Media S.A. 2024-12-01
סדרה:Frontiers in Cardiovascular Medicine
נושאים:
osimertinib
lung cancer
cardiac toxicity
echocardiogram
EGFR
גישה מקוונת:https://www.frontiersin.org/articles/10.3389/fcvm.2024.1485033/full

פריטים דומים

פריטים דומים